Jonathan Schechter - 15 Nov 2022 Form 4 Insider Report for Synaptogenix, Inc. (SNPX)

Role
Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Issuer symbol
SNPX
Transactions as of
15 Nov 2022
Net transactions value
$0
Form type
4
Filing time
17 Nov 2022, 15:01:24 UTC
Previous filing
23 Aug 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPX Stock Option (Right to Buy) Award $0 +72,000 $0.000000 72,000 15 Nov 2022 Common Stock, par value $0.0001 per share 72,000 $6.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer.